Skip to main content

Table 1 Description of the experimental groups

From: Adropin as a protective agent against renal ischemia-reperfusion injury induced by suprarenal aortic cross-clamping in rats

Group

Anesthesia Method

Surgical Procedure

Treatment

Ischemic Procedure

Reperfusion Time

Control Group

(N = 7)

50 mg/kg ketamine + 10 mg/kg xylazine (i.p.)

Laparotomy, bilayer abdominal incision model

Sterile saline (5% body weight) 30 min before the surgical procedures

-

24 h reperfusion

IR Group

(N = 7)

50 mg/kg ketamine + 10 mg/kg xylazine (i.p.)

Laparotomy, suprarenal aorta clamping, bilayer abdominal incision model

Sterile saline (5% body weight) 30 min before the surgical procedures

60 min of ischemia

24 h reperfusion

Treatment Group 1 (TR1)

(N = 7)

50 mg/kg ketamine + 10 mg/kg xylazine (i.p.)

Laparotomy, suprarenal aorta clamping, bilayer abdominal incision model

0.5 mg/kg Adropin (i.p.) application 30 min before the surgical procedures

60 min of ischemia

24 h reperfusion

Treatment Group 2 (TR2)

(N = 7)

50 mg/kg ketamine + 10 mg/kg xylazine (i.p.)

Laparotomy, suprarenal aorta clamping, bilayer abdominal incision model

1 mg/kg Adropin (i.p.) 30 min before the surgical procedures

60 min of ischemia

24 h reperfusion

Treatment Group 3 (TR3)

(N = 7)

50 mg/kg ketamine + 10 mg/kg xylazine (i.p.)

Laparotomy, suprarenal aorta clamping, bilayer abdominal incision model

1.5 mg/kg Adropin (i.p.) 30 min before the surgical procedures

60 min of ischemia

24 h reperfusion